Added to YB: 2026-05-06
Pitch date: 2026-05-04
MANE [neutral]
Veradermics, Incorporated
Author Info
Boursalogia shares ideas that are data-driven, high-conviction multibagger potential. Sign up for the newsletter.
Company Info
Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions.
Market Cap
$4.0B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.95
EV/Sales
N/A
Sector
Pharmaceuticals
Category
growth
MANE — The $30 Billion Secret Behind a Flawless IPO
MANE (overview): Oral hair loss treatment targeting $30B market, IPO'd at $17 then doubled to $34 on Feb 4. Addresses 80M US patients frustrated by topical minoxidil's 86% abandonment rate. First oral innovation in 30 years vs finasteride (1997), which faces lawsuit over side effects Merck hid. VDPHL01 not yet FDA approved—market buying promise. Up 199% since debut.
Read full article (14 min)